Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups
Background COVID-19 vaccines approved in the UK are highly effective in general
population cohorts, however, data on effectiveness amongst individuals with clinical
conditions that place them at increased risk of severe disease are limited. Methods We used
GP electronic health record data, sentinel virology swabbing and antibody testing within a
cohort of 712 general practices across England to estimate vaccine antibody response and
vaccine effectiveness against medically attended COVID-19 amongst individuals in clinical …
population cohorts, however, data on effectiveness amongst individuals with clinical
conditions that place them at increased risk of severe disease are limited. Methods We used
GP electronic health record data, sentinel virology swabbing and antibody testing within a
cohort of 712 general practices across England to estimate vaccine antibody response and
vaccine effectiveness against medically attended COVID-19 amongst individuals in clinical …
以上显示的是最相近的搜索结果。 查看全部搜索结果